Study objective: To investigate the distribution of reduction in lean body mass (LBM) and whether LBM in legs (LBMlegs) can be a determinant of maximal exercise performance in COPD patients. Methods: Thirty-eight male outpatients with COPD (mean ؎ SD FEV 1 , 47.4 ؎ 24.0% of predicted) who underwent complete pulmonary function testing were classified into two groups according to FEV 1 expressed as a percentage of predicted value. Group A comprised 21 patients with mild-to-moderate airflow limitation (FEV 1 > 35% predicted), and group B comprised 17 patients with severe airflow limitation (FEV 1 < 35% predicted). LBM, which represents skeletal muscle mass, was measured by dual energy x-ray absorptiometry (DXA) and was assessed separately in arms, legs, and trunk. Maximal oxygen uptake (V O 2 max) was measured during maximal exercise on a cycle ergometer. Key words: body composition analysis; COPD; distribution of peripheral muscle mass; dual energy x-ray absorptiometry; maximal exercise performance Abbreviations: BIA ϭ bioelectrical impedance analysis; Dlco ϭ diffusing capacity of the lung for carbon monoxide; DXA ϭ dual energy x-ray absorptiometry; FFM ϭ fat-free mass; IBW ϭ ideal body weight; LBM ϭ lean body mass; LBMarms ϭ LBM in arms; LBMlegs ϭ LBM in legs; LBMtrunk ϭ LBM in trunk; MVV ϭ maximal voluntary ventilation; RV ϭ residual volume; TLC ϭ total lung capacity; VC ϭ vital capacity; V e ϭ minute ventilation; V o 2 max ϭ maximal oxygen uptake P resently, body composition analysis is performed by bioelectrical impedance analysis (BIA) 1,2 and dual energy x-ray absorptiometry (DXA) 3,4 in patients with COPD. Fat-free mass (FFM) by BIA and lean body mass (LBM) by DXA, which represent muscle mass, were reported to be associated with respiratory muscle strength 2,3 and exercise performance. 4, 5 However, the distribution of muscle wasting has not been clearly elucidated. It would be useful to know the distribution for organization of the optimal training strategy for pulmonary rehabilitation because muscle strength is closely related to muscle mass in patients with COPD, 6 as well as in normal subjects. 7 Peripheral muscle strength 8,9 and oxidative capacity 10,11 were found to be related to exercise performance in COPD patients. In contrast, no significant effect of strength training on exercise perfor-
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resently, body composition analysis is performed by bioelectrical impedance analysis (BIA) 1,2 and dual energy x-ray absorptiometry (DXA) 3, 4 in patients with COPD. Fat-free mass (FFM) by BIA and lean body mass (LBM) by DXA, which represent muscle mass, were reported to be associated with respiratory muscle strength 2, 3 and exercise performance. 4, 5 However, the distribution of muscle wasting has not been clearly elucidated. It would be useful to know the distribution for organization of the optimal training strategy for pulmonary rehabilitation because muscle strength is closely related to muscle mass in patients with COPD, 6 as well as in normal subjects. 7 Peripheral muscle strength 8, 9 and oxidative capacity 10, 11 were found to be related to exercise performance in COPD patients. In contrast, no significant effect of strength training on exercise perfor-mance 12, 13 in COPD patients has been demonstrated. These data suggest that it is still unclear whether peripheral muscle function may determine the exercise performance in all patients with COPD, regardless of the severity.
The purpose of this study is to investigate the distribution of the reduction of LBM by DXA and to analyze the potential relationship between leg muscle mass and maximal exercise performance in COPD patients with various degrees of airflow limitation.
Materials and Methods

Subjects
Thirty-eight ambulatory male patients with COPD were recruited to participate in this study. The criteria for diagnosis of COPD were based on the standards of the American Thoracic Society. 14 The entry criteria included the following: (1) clinical diagnosis of COPD; (2) clinically stable condition (no recent infection or cardiac complaints); (3) absence of other pathologic conditions, including neuromuscular, metabolic, and malignant disease; and (4) not receiving oral corticosteroids. All patients had a history of cigarette smoking and evidence of COPD by spirometry.
The patients were classified into two groups on the basis of FEV 1 as a percentage of predicted value, using the criteria of the American Thoracic Society statement. 14 Group A consisted of 21 patients with mild-to-moderate airflow limitation in stage I or stage II (FEV 1 Ն 35% predicted). Group B consisted of 17 patients with severe airflow limitation in stage III (FEV 1 Ͻ 35% predicted).
The experimental protocol was approved by the Committee for Protection of Human Subjects, Nara Medical University, according to the Declaration of Helsinki. All the subjects gave their informed consent prior to the initiation of the study.
Pulmonary Function Tests
All patients underwent pulmonary function testing. Vital capacity (VC), FVC, FEV 1 , residual volume (RV), total lung capacity (TLC), and maximal voluntary ventilation (MVV) were measured using a pulmonary function instrument with computer processing (FUDAC 70; Fukuda Denshi; Tokyo, Japan), and the FEV 1 /FVC ratio was calculated. The values obtained were compared to the normal values of Berglund and coworkers. 15 Lung volumes were determined by the helium gas dilution method, and diffusing capacity of the lung for carbon monoxide (Dlco) was measured by the single-breath method.
Body Composition Analysis
Body composition was measured by DXA with a total body scanner (Lunar DPX; Lunar Radiation; Madison, WI) that uses a constant-potential x-ray generator and a K-edge filter (cerium) to separate the beam into high-energy and low-energy regions. The attenuated x-rays that passed through the subjects were measured with an energy-discriminating detector. The differential attenuation of the two energies was used to estimate the bone mineral content and soft-tissue mass. Bone mineral content and soft-tissue mass, partitioned into fat mass and LBM, were calculated separately based on the difference in mass attenuation coefficients. DXA makes it possible to analyze each body composition in accurate and reproducible fashion with very low radiation exposure. 16 The entire scanning from head to toe was usually completed within 15 min. LBM in subregions, including trunk, arms, and legs, can be determined separately as well as the whole body. LBM in trunk (LBMtrunk), LBM in arms (LBMarms), and LBM in legs (LBMlegs) were normalized for ideal body weight (IBW). 17 LBM in each region, expressed as a percentage of total LBM, LBMarms/total LBM, LBMlegs/total LBM, and LBMtrunk/total LBM, was also investigated.
Exercise Performance
All patients underwent maximal exercise tests on a cycle ergometer (STB-1350; Nihon Kohden; Tokyo, Japan). After 3 min of unloaded pedaling, the workload was increased by 10 W/min in a ramp protocol until exhaustion. Gas exchange was monitored during the exercise test with a computerized metabolic cart (Vmax 229; SensorMedics; Yorba Linda, CA). Minute ventilation (V e), oxygen uptake, and carbon dioxide output were measured by the breath-by-breath method. Arterial oxygen saturation was also monitored using pulse oximetry (BSM-8500; Nihon Kohden; Tokyo, Japan).
Statistical Analysis
Values obtained were expressed as mean Ϯ SD. The differences among measured parameters in the two groups were determined by unpaired t tests. Pearson's correlation coefficients among static lung function, LBM, and maximal oxygen uptake (V o 2 max) were calculated. Stepwise multiple regression analysis was performed to determine the best predictors of V o 2 max. LBMlegs/IBW and pulmonary function, which showed significant correlation with V o 2 max, were selected as independent variables in this analysis. The level of statistical significance for each test was set as p Ͻ 0.05.
Results
Anthropometric and Pulmonary Function Data
Anthropometric characteristics and pulmonary function data of the two patient groups are described in Table 1 . There was no significant difference in age and height, although the percentage of IBW and body mass index were statistically different between the two groups. VC, FEV 1 , and MVV in group B were significantly lower than those in group A, while RV/TLC and Paco 2 were significantly higher in group B. Dlco and Pao 2 showed no significant difference between the two groups.
Distribution of LBM
The total LBM and distribution of LBM in the two groups are shown in Table 2 . Absolute values of LBM in total, trunk, arms, and legs in group B were significantly lower than those in group A. LBMtrunk/ IBW, LBMarms/IBW, and LBMlegs/IBW were significantly depleted in group B. LBMtrunk/total LBM in group B was comparable to that in group A.
There was no significant difference in LBMarms/ total LBM between the two groups (p ϭ 0.25). In contrast, LBMlegs/total LBM was significantly decreased in group B (p ϭ 0.02).
Exercise Performance
Physiologic variables during maximal cycle ergometry in the two groups are summarized in Table 3 . Maximal V e, maximal work rate, and V o 2 max in group B were significantly lower than those in group A. Maximal V e/MVV was significantly higher in group B, while no difference was observed in maximal heart rate as a percentage of predicted between the two groups. There was no difference in arterial oxygen desaturation during maximal exercise between the two groups.
Determinants of V O 2 max
Correlation coefficients between V o 2 max and pulmonary function and LBM are shown in Table 4 . FEV 1 , RV/TLC, and MVV correlated significantly with V o 2 max in both groups. Although total LBM/ IBW and LBMlegs/IBW correlated significantly with V o 2 max in group A, they did not have significant correlations with V o 2 max in group B.
We also found a significant correlation between LBMlegs/IBW and V o 2 max in total group (r ϭ 0.66, p Ͻ 0.0001; Fig 1) . In addition, there was no significant correlation between LBMtrunk/IBW and V o 2 max in group A or group B (p ϭ 0.26 and p ϭ 0.09, respectively; data not shown).
Stepwise multiple regression analysis was performed to determine the best combination of predictors for V o 2 max (Table 5 ). MVV and LBMlegs/ IBW appeared to be significant determinants of V o 2 max in group A. Total variance explained in this model for V o 2 max was 77% in group A. In contrast, LBMlegs/IBW was not selected as a significant predictor in group B. Only 44% of total variance was explained in this model for V o 2 max.
Discussion
In the present study, we measured LBM by DXA and assessed it separately in arms, legs, and trunk. It was shown that a significant reduction of LBM, expressed as a percentage of IBW in each region, was present in patients with severe airflow limitation compared to patients with mild-to-moderate airflow limitation.
DXA has been validated against independent methods, including ␥-neutronactivation model, total body potassium, and hydrodensitometry, and is becoming one of the reference methods for body composition analysis. 18 BIA is an another recent method of body composition analysis. Schols and coworkers 5 have demonstrated that FFM measured by BIA, which was almost equivalent to LBM, was a better indicator of body-mass depletion than body weight in patients with clinically stable COPD. However, BIA was reported to overestimate FFM. 18 Furthermore, whole-body DXA systems in contrast with BIA allow regional measurements, and this permits separation of the extremity from the trunk measurements. DXA makes it possible to quantify *Values are presented as mean Ϯ SD. WRmax ϭ maximal work rate; HRmax ϭ maximal heart rate; ⌬Spo 2 ϭ the difference in arterial oxygen saturation between at rest and at maximal exercise. †p Ͻ 0.001 for the difference between group A and group B. ‡p Ͻ 0.01 for the difference between group A and group B.
skeletal muscle mass of the extremities, because the fat-free soft tissue of the extremities is almost entirely skeletal muscle, except for a small amount of skin connective tissues.
To investigate the distribution of muscle-mass wasting, LBM of each subregion expressed as a percentage of total LBM was evaluated. LBMlegs/ total LBM was significantly reduced in patients with severe airflow limitation, while no significant difference in LBMtrunk/total LBM and LBMarms/total LBM between the two groups was observed. This finding may suggest that patients with severe disease exhibited disproportional leg muscle wasting. In states associated with simple muscle atrophy, such as nutritional depletion, the loss of upper-limb muscle function is equal to or greater than that of the lower limbs. 19 However, the distribution of muscle wasting found in patients with severe disease who were more severely malnourished than those with mild-to-moderate disease is not consistent with atrophy induced by malnutrition. The disproportional leg muscle wasting in patients with severe disease may attribute to the limitation in their daily activity due to limited respiratory reserve.
In this study, a matched healthy control group was not included. As the absence of a control group has limited quantitative estimation of total LBM and distribution of LBM in each group, it is not clearly defined whether muscle wasting is also a characteristic of patients with mild-to-moderate COPD.
The impact of peripheral muscle function on exercise performance has been investigated. Peripheral muscle weakness, 8, 9 , reduction in oxidative enzyme activities, 10, 11 and a low proportion of type I myosin heavy chain 20 have been reported to contribute to exercise intolerance in COPD. However, the relationship between peripheral muscle mass and exercise performance has not been clearly elucidated. In the present study, LBMlegs was found to be a significant predictor of V o 2 max in patients with mild-to-moderate COPD. This finding may be reasonable because the mass of exercising muscles, as well as the dimensions of the cardiovascular and pulmonary systems, should determine the maximal quantity of oxygen that could be delivered and used. 21 Excessive increase in blood lactic acid in COPD patients during exercise compared with normal subjects is associated with exercise limitation. Previously, a reduction in oxidative enzyme activity, including citrate synthase and 3-hydroxyacyl-coenzyme A dehydrogenase in biopsy specimens from the quadriceps femoris muscle 10, 11 and a strong correlation between the activity of these enzymes anḋ Vo 2 max, have been demonstrated. 11 It is unclear whether a decrease in enzyme activities may attribute to either a loss of muscle mass, to some alteration in muscle structure, or to a combination of these two mechanisms. Our data suggest that a loss of muscle mass may contribute to the decrease in oxidative enzyme activity. In addition, Kutsuzawa and coworkers 22 found an early activation of anaerobic glycolysis during exercise in patients with COPD and demonstrated a significant correlation between indexes of this early activation and muscle mass. Our observations are consistent with their statement that muscle atrophy may contribute to the metabolic changes in muscles.
We previously reported that total LBM was a significant determinant of V o 2 max in stepwise regression analysis in patients with COPD (mean FEV 1 , 49.8 Ϯ 26.4% of predicted). However, LBM in each subregion was not evaluated and the relation of leg muscle mass, which was mainly recruited for cycle ergometer exercise, to V o 2 max was not investigated. In the present study, an independent effect of leg muscle mass on V o 2 max was demonstrated in COPD patients with mild-to-moderate airflow limitation, while not in patients with severe disease. Furthermore, no significant correlation between LBMtrunk/IBW and V o 2 max was observed in both groups in this study. These data may suggest that LBM in each subregion has a different effect on V o 2 max.
Several reports 12, 13 demonstrated that strength training of leg muscles provided no significant improvements of V o 2 max and 6-min walk distance, although it contributes to an increase in muscle strength. We found that leg muscle mass was a significant predictor of V o 2 max in patients with mild-to-moderate airflow limitation, but not in patients with severe airflow limitation. Richardson and coworkers 23 documented that the patients with severe COPD had significant skeletal muscle metabolic reserve at maximal exercise and concluded that reduced whole-body exercise capacity was the result of central restraints, rather than peripheral skeletal muscle dysfunction in these patients. These findings suggest that it may depend on the severity of the disease as to whether strength training of leg muscles can improve V o 2 max.
In addition, Berry and coworkers 24 have shown that peak oxygen consumption increased significantly after exercise training in patients with mild COPD, while the increase was insignificant in patients with moderate and severe COPD. A therapeutic approach to a reduction of central restraints (ie, lung volume reduction surgery) may be required for a substantial improvement of V o 2 max in patients with severe airflow limitation. 25, 26 In conclusion, we found disproportional reduction of LBMlegs in COPD patients with severe airflow limitation. However, LBMlegs was not a significant predictor of V o 2 max in these patients.
